Antitubercular nanocarrier monotherapy: study of in vivo efficacy and pharmacokinetics for rifampicin

TROUSIL, J., PAVLIŠ, O., KUBÍČKOVÁ, P., ŠKORIČ, M., MAREŠOVÁ, V., PAVLOVA, E., KNUDSEN, K. D., DAI, Y.-S., ZIMMERMAN, M., DARTOIS, V., FANG, J.-Y., HRUBÝ, M. Antitubercular nanocarrier monotherapy: study of in vivo efficacy and pharmacokinetics for rifampicin. Journal of Controlled Release. 2020, 321(10 May), 312-323. ISSN 0168-3659. E-ISSN 1873-4995. Available: doi: 10.1016/j.jconrel.2020.02.026.